% alzhub.org library filter
% Source: https://alzhub.org/research?author=Sabbagh+MN&about=clinical-trials
% 12 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{honig2024-38730496,
  author  = {Honig, L. S. and Sabbagh, M. N. and van Dyck, C. H. and Sperling, R. A. and Hersch, S. and Matta, A. and Giorgi, L. and Gee, M. and others},
  title   = {{Updated safety results from phase 3 lecanemab study in early Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01441-8},
  pmid    = {38730496},
  url     = {https://doi.org/10.1186/s13195-024-01441-8}
}

@article{salloway2018-29914022,
  author  = {Salloway, S. P. and Sperling, R. and Fox, N. C. and Sabbagh, M. N. and Honig, L. S. and Porsteinsson, A. P. and Rofael, H. and Ketter, N. and others},
  title   = {{Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2018},
  doi     = {10.3233/jad-171157},
  pmid    = {29914022},
  url     = {https://doi.org/10.3233/jad-171157}
}

@article{rafii2022-35532913,
  author  = {Rafii, M. S. and Sol, O. and Mobley, W. C. and Delpretti, S. and Skotko, B. G. and Burke, A. D. and Sabbagh, M. N. and Yuan, S. H. and others},
  title   = {{Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.0983},
  pmid    = {35532913},
  url     = {https://doi.org/10.1001/jamaneurol.2022.0983}
}

@article{curtis2015-25622185,
  author  = {Curtis, C. and Gamez, J. E. and Singh, U. and Sadowsky, C. H. and Villena, T. and Sabbagh, M. N. and Beach, T. G. and Duara, R. and others},
  title   = {{Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2014.4144},
  pmid    = {25622185},
  url     = {https://doi.org/10.1001/jamaneurol.2014.4144}
}

@article{galasko2014-24696507,
  author  = {Galasko, D. and Bell, J. and Mancuso, J. Y. and Kupiec, J. W. and Sabbagh, M. N. and van Dyck, C. and Thomas, R. G. and Aisen, P. S. and others},
  title   = {{Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease}},
  journal = {Neurology},
  year    = {2014},
  doi     = {10.1212/wnl.0000000000000364},
  pmid    = {24696507},
  url     = {https://doi.org/10.1212/wnl.0000000000000364}
}

@article{sabbagh2011-21192237,
  author  = {Sabbagh, M. N. and Agro, A. and Bell, J. and Aisen, P. S. and Schweizer, E. and Galasko, D.},
  title   = {{PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2011},
  doi     = {10.1097/wad.0b013e318204b550},
  pmid    = {21192237},
  url     = {https://doi.org/10.1097/wad.0b013e318204b550}
}

@article{sparks2005-15883262,
  author  = {Sparks, D. L. and Sabbagh, M. N. and Connor, D. J. and Lopez, J. and Launer, L. J. and Browne, P. and Wasser, D. and Johnson-Traver, S. and others},
  title   = {{Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results}},
  journal = {Archives of neurology},
  year    = {2005},
  doi     = {10.1001/archneur.62.5.753},
  pmid    = {15883262},
  url     = {https://doi.org/10.1001/archneur.62.5.753}
}

@article{johnson2013-23375563,
  author  = {Johnson, K. A. and Sperling, R. A. and Gidicsin, C. M. and Carmasin, J. S. and Maye, J. E. and Coleman, R. E. and Reiman, E. M. and Sabbagh, M. N. and others},
  title   = {{Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2013},
  doi     = {10.1016/j.jalz.2012.10.007},
  pmid    = {23375563},
  url     = {https://doi.org/10.1016/j.jalz.2012.10.007}
}

@article{sparks2006-16866904,
  author  = {Sparks, D. L. and Connor, D. J. and Sabbagh, M. N. and Petersen, R. B. and Lopez, J. and Browne, P.},
  title   = {{Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial}},
  journal = {Acta neurologica Scandinavica. Supplementum},
  year    = {2006},
  doi     = {10.1111/j.1600-0404.2006.00690.x},
  pmid    = {16866904},
  url     = {https://doi.org/10.1111/j.1600-0404.2006.00690.x}
}

@article{sabbagh2023-37695107,
  author  = {Sabbagh, M. N. and Mathew, P. and Blau, A.},
  title   = {{A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2023},
  doi     = {10.1097/wad.0000000000000578},
  pmid    = {37695107},
  url     = {https://doi.org/10.1097/wad.0000000000000578}
}

@article{sparks2002-12474023,
  author  = {Sparks, D. L. and Connor, D. J. and Browne, P. J. and Lopez, J. E. and Sabbagh, M. N.},
  title   = {{HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier}},
  journal = {The journal of nutrition, health \& aging},
  year    = {2002},
  pmid    = {12474023}
}

@article{vitek2023-36749830,
  author  = {Vitek, G. E. and Decourt, B. and Sabbagh, M. N.},
  title   = {{Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease}},
  journal = {Expert opinion on investigational drugs},
  year    = {2023},
  doi     = {10.1080/13543784.2023.2178414},
  pmid    = {36749830},
  url     = {https://doi.org/10.1080/13543784.2023.2178414}
}